항암요법 중인 원발성 비소세포폐암 환자의 증상 부담, 자기효능감, 스티그마가 암 대처에 미치는 영향

Abstract

Purpose: The purpose of this study was to identify effects of symptom burden, self-efficacy, and stigma on cancer coping in patients with primary non-small cell lung cancer (NSCLC) undergoing chemotherapy. Methods: Data were collected from 140 patients receiving chemotherapy for NSCLC at the outpatient clinic of the respiratory department of a tertiary hospital in City B between February 3 and April 30, 2025. The data were analyzed using SPSS/WIN 28.0, and independent t-tests, one-way ANOVA, Pearson’s correlation coefficient, and hierarchical multiple regression analysis were applied. Results: Intrapersonal coping was found to be significantly correlated with symptom severity, symptom interference with daily life, stigma, and self-efficacy. Meanwhile, interpersonal coping was significantly correlated with symptom interference, stigma, and self-efficacy. Hierarchical regression analysis revealed that self-efficacy, symptom interference, and age were significant predictors of intrapersonal coping. In addition, marital status, self- efficacy, and stigma were identified as significant predictors of interpersonal coping. Conclusion: The findings highlight the importance of psychosocial and symptom-related factors, particularly self-efficacy, in supporting effective coping strategies among NSCLC patients undergoing chemotherapy. Tailored interventions that enhance self-efficacy and address stigma and symptom management may contribute to improved coping outcomes.